Publication:
Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade

Thumbnail Image

Open/View Files

5616196.pdf (351.37 KB)

Date

2017

Authors

Published Version

10.18632/oncoscience.359

Journal Title

Journal ISSN

Volume Title

Publisher

Impact Journals LLC
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Saha, Dipongkor, Robert L. Martuza, and Samuel D. Rabkin. 2017. “Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade.” Oncoscience 4 (7-8): 67-69. doi:10.18632/oncoscience.359. http://dx.doi.org/10.18632/oncoscience.359.

Research Data

Abstract

Description

Other Available Sources

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616196/pdf/

Keywords

oncolytic virus, herpes simplex virus, cancer stem cells, immunotherapy, immune checkpoint

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

URI

http://nrs.harvard.edu/urn-3:HUL.InstRepos:34491823

Collections

HMS Scholarly Articles

Endorsement

Review

Supplemented By

Referenced By

Related Stories